Navigation Links
Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
Date:3/20/2009

RIDGEFIELD, Conn., March 20 /PRNewswire/ -- Boehringer Ingelheim today announced that the last patient has completed treatment in the Phase III Randomized Evaluation of Long term Anticoagulant therapy (RE-LY(R)) study. This study compared the long-term efficacy and safety of the oral direct thrombin inhibitor dabigatran etexilate with the current standard therapy, warfarin (target international normalized ratio, INR, 2-3) for the prevention of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF). Dabigatran etexilate is an oral anticoagulant in Phase III development for stroke prevention in AF, as well as several other therapeutic areas. Dabigatran etexilate is not approved by the FDA. RE-LY(R) is the largest AF stroke prevention trial to date. The study enrolled 18,113 patients in more than 900 centers in 44 countries worldwide between December 2005 and December 2007. Data will now be analyzed and results are expected to be presented later this year at the European Society of Cardiology (ESC) Congress, taking place in Barcelona, Spain, from August 29th until September 2nd.

"We are delighted with the completion of treatment in the RE-LY study as it marks an important milestone in the ongoing development of dabigatran etexilate," said Paul Reilly, clinical program director, Boehringer Ingelheim. "We are grateful to the patients and investigators who participated in the study and look forward to further evaluating the safety and efficacy of dabigatran through the analysis of the data."

Atrial fibrillation affects more than 2.2 million Americans, making it the most common heart rhythm disorder in the U.S.(1) People with AF are at increased risk for forming blood clots in their hearts(2) which can raise their risk of stroke five-fold.(3) However, clinical studies show that up to 60 percent of AF related strokes can be prevented with appropriate anticoagulant therapy.(4) Vitamin K antagonists are the c
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Photos: Eight Finalists Lose 685 Pounds and Gain $800,000
2. Clinical Data from Plastic Surgeon in New Jersey Helped in Final Determination of 2008's Top Plastic Surgery Procedures
3. USPTO Issues Notice of Final Determination for Patent Term Extension for NAMENDA(R)
4. Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets
5. Nuvos High Throughput Experimentation Platform Selected as 2009 Edison Award Finalist
6. EMPLOYER SURVEY - Final Opportunity to Participate in the UBA Employer Benefits Perspective Survey
7. Final Economic Stimulus Bill Permits Americans Personal Health Information to Be Sold for Research and Public Health Purposes WITHOUT Patients Consent
8. The NBA Teams up With Body By Milk to Challenge Teenagers to Get Fit By Finals
9. OmniPod(R) Insulin Management System Selected as a Finalist for the 2009 Edison Best New Product Awards(TM)
10. Samplify Systems SAM1600 Family of Analog/Digital Converters Named Finalist in EDN Magazines 19th Annual Innovation Awards
11. Final House Vote on SCHIP Delivers Peace of Mind to Americas Families
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... September 30, 2014 EverStryke , the ... introduction to SurvivalLife.com along with a free book and class ... of Shane Michaels, prompting an investigative review. , “Joe ... in the survival and preparation niche, and this product is ... great classes and survival products that Joe offers on his ...
(Date:9/30/2014)... 30, 2014 The American Diabetes ... help diabetics curb their sweet tooth, but the most ... this September, suggests that zero-calorie sweeteners may actually be ... , The Weizmann Institute of Science in Israel ... sweeteners to mice, the mice developed glucose intolerance. They ...
(Date:9/30/2014)... 30, 2014 Hospice & Palliative ... “In Celebration” gala, honoring three outstanding individuals for ... striving to provide extraordinary and dignified comfort, care ... serious or life-limiting illness. , The event was ... NY and recognized William (Bill) J. McGuinness, Director ...
(Date:9/30/2014)... Washington, DC (PRWEB) September 30, 2014 A ... the world to combat an epidemic that, left unchecked, could ... no, they are not headed to Africa. John Rogers, the ... headed to North Korea to fight a disease most think ... the US some 80 years ago is on the comeback ...
(Date:9/30/2014)... Bifidobacteria, the primary bacteria found in the large ... so a high Bifido probiotic can help replenish this ... Men’s Complete contains 90 Billion live probiotic cultures, ... support a healthy large intestine (colon) where elimination occurs ... cultures from 7 Lactobacillus strains to help maintain a ...
Breaking Medicine News(10 mins):Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2Health News:ReNew Life Introduces Ultimate Flora™ Men’s Complete Probiotic 90 Billion—Comprehensive Probiotic Support Just for Men 2
... But now after bringing in changes in their sexual behavior, by ... and using condoms have greatly reduced the number of people suffering ... among women in the age group of 15-24 the prevalence of ... in the age group of 17-29. ,Hence the researcher, ...
... Asian peninsula. A new case of a 15-year-old boy who tested ... the Indonesian town of Bandung.// , ,In case the local ... it will become the 15th human fatality from bird flu in ... Bandung regency, some150 km south of Jakarta. He was admitted to ...
... flu have been reported in Iraq’s northern Kurdish region, after the ... The // region’s diagnosis center has admitted the people who are ... of the north bordering Turkey is reported to have many infections. ... Turkey, which has seen four deaths and a number of suspected ...
... colliding with each other, according to scientists. The researchers also ... subduction zone. At subduction zones, one tectonic plate pushes over ... kilometers of subduction zones and the motion along the margins ... per year. ,According to researchers, where the ...
... have expressed their disappointment over the inadequate monitoring of ... infected with hepatitis C // during 1970 and 1980. ... in 1991, which led many campaigners, mostly hemophiliacs question ... ,The Holy rood health committee was considering demands ...
... reported the results of the study in New England ... trial conducted in 68 patients over // the benefits ... treatment of Schizophrenia. ,The researchers found that ... the symptoms of Schizophrenia and the results of combination ...
Cached Medicine News:
(Date:9/30/2014)... ST. PAUL, Minn. , Sept. 30, 2014 /PRNewswire/ ... the United States abused prescription pain ... dependence include detoxification or maintenance treatment, which entails the ... and costs of these treatments are important when developing ... studies by pharmacy benefit manager Prime Therapeutics ...
(Date:9/30/2014)... SAN DIEGO , Sept. 30, 2014 /PRNewswire/ ... a three-dimensional biology company focused on delivering breakthrough ... Human Liver Model has been selected as a finalist ... the 2014 Most Innovative New Product Awards, sponsored ... creation of innovative technology and life sciences products ...
(Date:9/30/2014)... -- , A series of Health ... change the way retail pharmaceutical companies are perceived   ... and view pharmacies, Health First Pharmacy is redefining the ... very trendy public demands of customisation and accessibility, the ... various activities for both children and adults starting from ...
Breaking Medicine Technology:Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3Health First Pharmacy Redefines 'Pharmacy Retail Experience' 2Health First Pharmacy Redefines 'Pharmacy Retail Experience' 3
... , , NEW YORK , ... Jay Hoffman , PhD, professor and chair of the Department of ... , has shown Sustamine™ L-Alanyl-L-Glutamine, increases performance in endurance exercise and ... in the Journal of the International Society of Sports Nutrition ...
... , SEATTLE , Feb. 11 ... today announced record 2009 sales results. The successful launch of ... in excess of 75% and the company,s first cash flow ... the company,s manufacturing capacity for 2009 and well into 2010. ...
Cached Medicine Technology:Clinical Study Shows Sustamine(TM) L-Alanyl-L-Glutamine Increases Performance in Endurance, Exercise and Activity 2Clinical Study Shows Sustamine(TM) L-Alanyl-L-Glutamine Increases Performance in Endurance, Exercise and Activity 3Clinical Study Shows Sustamine(TM) L-Alanyl-L-Glutamine Increases Performance in Endurance, Exercise and Activity 4Amnis Announces Record 2009 Sales 2
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: